United States v. Samirkumar Shah

CourtCourt of Appeals for the Third Circuit
DecidedJuly 22, 2022
Docket21-2581
StatusUnpublished

This text of United States v. Samirkumar Shah (United States v. Samirkumar Shah) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Samirkumar Shah, (3d Cir. 2022).

Opinion

NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ______________

No. 21-2581 ______________

UNITED STATES OF AMERICA

v.

SAMIRKUMAR J. SHAH, Appellant ______________

On Appeal from the United States District Court for the Western District of Pennsylvania (D.C. Crim. Action No. 2-16-cr-00110-001) U.S. District Judge: Honorable David S. Cercone ______________

Submitted Under Third Circuit L.A.R. 34.1(a) July 8, 2022 ______________

Before: SHWARTZ, KRAUSE, and ROTH, Circuit Judges.

(Filed: July 22, 2022) ______________

OPINION ∗ ______________

∗ This disposition is not an opinion of the full court and pursuant to I.O.P. 5.7 does not constitute binding precedent. SHWARTZ, Circuit Judge.

Samirkumar Shah appeals his conviction and sentence for health care fraud.

Because the District Court correctly denied his motions to disqualify the United States

Attorney’s Office (“USAO”), for a continuance, and for a judgment of acquittal, and

because his sentence is procedurally and substantively reasonable, we will affirm.

I

A

Shah practiced cardiology in multiple offices in Pennsylvania. Among other

things, Shah prescribed external counterpulsion (ECP) treatment, which is designed to

increase blood flow to the heart using compression cuffs around the patient’s legs while

they are lying down. Shah purchased ECP beds and billed insurers, including Medicaid

and Medicare plans, for ECP treatment.

Medicaid and Medicare have three limitations for reimbursement of ECP

treatment. First, the programs cover ECP treatment only for patients who suffer from

angina (chest pain). Second, the programs will only reimburse for ECP treatment that

was conducted under a physician’s direct supervision. Third, the programs restrict billing

for reimbursement. Specifically, a system of codes is used to identify the service

rendered, and each coded service is assigned a price. ECP treatment is assigned code

G0166, which is a “bundled code” because it includes companion treatments. 1 App. 197.

As result, physicians who bill code G0166 may not also bill the separate codes for the

1 The companion treatments bundled in G0166 include echocardiograms, Doppler tests, pulse oximetries, and plethysmographies. 2 companion treatments on the same day “unless they are medically necessary and

delivered in a clinical setting not involving ECP therapy.” S. App. 6. The ECP bed

supplier provided Shah with guidelines informing him of these limitations.

Insurers audited Shah’s billing and told him that he improperly billed ECP

treatments by using both the G0166 code and codes for companion treatments and that

the medical necessity of many of his ECP treatments was unsubstantiated. Although

Shah’s agreements with insurers required that he only seek reimbursement for medically

necessary treatments, and he told one insurer that he instructed his billing department to

remove the incorrect codes, he in fact directed his third-party billing service to continue

billing “[a]ll four codes.” App. 836.

In addition to ignoring insurers’ directives, Shah (1) prescribed ECP for patients,

including an undercover agent, who did not suffer chest pain, telling some patients that

ECP treatment would make them “younger and smarter” and could help with conditions

including high and low blood pressure, obesity, erectile dysfunction, and restless leg

syndrome, App. 385; and (2) was “very often” not present—nor was any doctor—to

supervise patients’ ECP treatments, App. 457-58. Shah (1) told his staff that all patients

had angina; (2) instructed staff to “beef[] up” patient files before insurance reviews, long

after treatment was provided, App. 327; and (3) used pre-printed forms that included

angina diagnoses. Notably, during an interview with the Pennsylvania Attorney

General’s Office, Shah stated that he reported angina diagnoses for patients who did not

have that condition “[f]or reimbursement purposes.” App. 1151.

3 B

A grand jury indicted Shah for two counts of health care fraud in violation of 18

U.S.C. § 1347.

On the first day of jury selection, Shah moved to disqualify the entire USAO and

sought a continuance to conduct additional discovery.

Shah’s disqualification motion arose out of his prior representation by Tina Miller,

who represented Shah until June 2017, and then, ten months later, joined the USAO as a

supervisory Assistant U.S. Attorney (“AUSA”). Shah argued that because Miller became

a supervisor in the office prosecuting him, there was “both a conflict of interest and an

appearance of a loss of impartiality.” D. Ct. ECF No. 145 at 7. The District Court denied

the motion, noting that it did not “see any issue of any facts demonstrating a conflict of

[interest]” and emphasizing the need to avoid delaying the trial. App. 67. 2

Shah also sought a continuance so he could have an expert review 350 patient files

seized from his offices. The Government responded that the records had been available

2 After the Court ruled, it received declarations from Miller and the two AUSAs handling the trial. Miller stated that she did not discuss employment with the USAO when she represented Shah and, once she joined the office, she had no discussions about or involvement in any cases in which she had played a role while in private practice. She also represented that she divulged no confidential information learned during her representation of Shah to any USAO employee or investigative agency. The two AUSAs’ affidavits likewise stated that Miller was not involved in Shah’s prosecution and did not divulge any client confidences. One AUSA added that her only discussion with Miller regarding Shah’s prosecution involved her telling Miller that she was unable to assist on a separate matter because she, unbeknownst to Miller, “would be in . . . the trial of [Shah].” App. 90. After trial, the District Court revisited Shah’s disqualification motion, again held that disqualification of the entire USAO was inappropriate “given the lack of . . . Miller’s 4 to him for years and thus a continuance was inappropriate. The Court denied the request

for a continuance as untimely.

C

The trial commenced, and the Government presented thirty-two witnesses,

including Shah’s patients and employees, the ECP bed supplier, insurers, his third-party

billing service, and law enforcement officers. After the government rested, Shah moved

for judgment of acquittal on Count Two, which the District Court denied. The jury found

Shah guilty on both counts of health care fraud.

D

The District Court held a sentencing hearing to calculate the loss to insurers from

Shah’s conduct. FBI Special Agent Brooklynn Riordan testified that, for each insurer,

she calculated (1) the average amount Shah billed and (2) the average amount the insurer

reimbursed Shah, and identified, by dividing the average amount reimbursed by the

average amount billed, a reimbursement rate. She then multiplied that rate by the total

billing to that insurer, which, across all insurers, yielded a total loss of $5,919,100.00.

The Government recommended reducing the total loss amount by 50%, which had the

effect of treating half of Shah’s billing for ECP treatment and companion codes as

legitimate, even though there was no evidence that he ever legitimately used those codes.

The District Court accepted the loss calculation over Shah’s objection.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Merced
603 F.3d 203 (Third Circuit, 2010)
Ungar v. Sarafite
376 U.S. 575 (Supreme Court, 1964)
Rita v. United States
551 U.S. 338 (Supreme Court, 2007)
United States v. Jones
641 F.3d 706 (Sixth Circuit, 2011)
United States v. Stephen Goot
894 F.2d 231 (Seventh Circuit, 1990)
United States v. Yu Kikumura
947 F.2d 72 (Third Circuit, 1991)
United States v. Fumo
655 F.3d 288 (Third Circuit, 2011)
United States v. Miell
661 F.3d 995 (Eighth Circuit, 2011)
United States v. John Voigt
89 F.3d 1050 (Third Circuit, 1996)
United States v. Wayne Whittaker
268 F.3d 185 (Third Circuit, 2001)
United States v. Robert E. Brennan
326 F.3d 176 (Third Circuit, 2003)
United States v. Elvis Irizarry
341 F.3d 273 (Third Circuit, 2003)
United States v. Albert Tupone
442 F.3d 145 (Third Circuit, 2006)
United States v. Roy Hebron
684 F.3d 554 (Fifth Circuit, 2012)
United States v. Ali
508 F.3d 136 (Third Circuit, 2007)
United States v. Tomko
562 F.3d 558 (Third Circuit, 2009)
State v. Tippecanoe County Court
432 N.E.2d 1377 (Indiana Supreme Court, 1982)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Samirkumar Shah, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-samirkumar-shah-ca3-2022.